A T-cell response to a liver-stage Plasmodium antigen is not boosted by repeated sporozoite immunizations

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 15, 2013, Pages 6055-6060

  Murphy, Sean C ^a   Kas, Arnold ^b   Stone, Brad C ^b   Bevan, Michael J ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b BENAROYA RESEARCH INSTITUTE   (United States)

Author keywords

Epitope; Vaccination

Indexed keywords

CIRCUMSPOROZOITE PROTEIN; PROTEIN; RIBOSOME PROTEIN L3; SPOROZOITE VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CYTOTOXIC T LYMPHOCYTE; HIGH THROUGHPUT SCREENING; IMMUNIZATION; LIVER; MOUSE; NONHUMAN; PARASITE LOAD; PLASMODIUM; PLASMODIUM YOELII; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPOROZOITE;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL SEPARATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; IMMUNIZATION; IMMUNOPHENOTYPING; INTERFERON-GAMMA; MALARIA VACCINES; MICE; MICE, INBRED BALB C; PEPTIDES; PLASMODIUM YOELII; PROTOZOAN PROTEINS; SEQUENCE ANALYSIS, DNA; SPOROZOITES; T-LYMPHOCYTES;

MUS; PLASMODIUM PARASITES; PLASMODIUM YOELII;

EID: 84876069319     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1303834110     Document Type: Article

References (53)

1. Nussenzweig RS, Vanderberg J, Most H, Orton C (1967) Protective immunity produced by the injection of x-irradiated sporozoites of plasmodium berghei. Nature 216(5111):160-162.
2. Clyde DF, Most H, McCarthy VC, Vanderberg JP (1973) Immunization of man against sporozite-induced falciparum malaria. Am J Med Sci 266(3):169-177.
3. Mueller AK, Labaied M, Kappe SH, Matuschewski K (2005) Genetically modified Plasmodium parasites as a protective experimental malaria vaccine. Nature 433(7022):164-167.
4. Putrianti ED, Silvie O, Kordes M, Borrmann S, Matuschewski K (2009) Vaccine-like immunity against malaria by repeated causal-prophylactic treatment of liver-stage Plasmodium parasites. J Infect Dis 199(6):899-903.
5. Roestenberg M, et al. (2009) Protection against a malaria challenge by sporozoite inoculation. N Engl J Med 361(5):468-477.
6. Doolan DL, Hoffman SL (2000) The complexity of protective immunity against liverstage malaria. J Immunol 165(3):1453-1462.
7. Kumar S, et al. (1988) Cytotoxic T cells specific for the circumsporozoite protein of Plasmodium falciparum. Nature 334(6179):258-260.
8. Romero P, et al. (1989) Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature 341(6240):323-326.
9. Stewart MJ, Vanderberg JP (1988) Malaria sporozoites leave behind trails of circumsporozoite protein during gliding motility. J Protozool 35(3):389-393.
10. Bongfen SE, Torgler R, Romero JF, Renia L, Corradin G (2007) Plasmodium bergheiinfected primary hepatocytes process and present the circumsporozoite protein to specific CD8+ T cells in vitro. J Immunol 178(11):7054-7063.
11. Kumar KA, Baxter P, Tarun AS, Kappe SH, Nussenzweig V (2009) Conserved protective mechanisms in radiation and genetically attenuated uis3 (-) and uis4 (-) Plasmodium sporozoites. PLoS ONE 4(2):e4480.
12. Balam S, Romero JF, Bongfen SE, Guillaume P, Corradin G (2012) CSP-a model for in vivo presentation of Plasmodium berghei sporozoite antigens by hepatocytes. PLoS ONE 7(12):e51875.
13. Rénia L, et al. (1991) In vitro activity of CD4+ and CD8+ T lymphocytes from mice immunized with a synthetic malaria peptide. Proc Natl Acad Sci USA 88(18):7963-7967.
14. Rénia L, et al. (1993) Effector functions of circumsporozoite peptide-primed CD4+ T cell clones against Plasmodium yoelii liver stages. J Immunol 150(4):1471-1478.
15. Molano A, et al. (2000) Cutting edge: The IgG response to the circumsporozoite protein is MHC class II-dependent and CD1d-independent: Exploring the role of GPIs in NK T cell activation and antimalarial responses. J Immunol 164(10):5005-5009.
16. Rodrigues MM, et al. (1991) CD8+ cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria. Int Immunol 3(6):579-585.
17. Schmidt NW, et al. (2008) Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malaria. Proc Natl Acad Sci USA 105(37):14017-14022.
18. Barbosa A, et al. (2009) Plasmodium falciparum-specific cellular immune responses after immunization with the RTS, S/AS02D candidate malaria vaccine in infants living in an area of high endemicity in Mozambique. Infect Immun 77(10):4502-4509.
19. Pichyangkul S, et al. (2008) Preclinical evaluation of the safety and immunogenicity of a vaccine consisting of Plasmodium falciparum liver-stage antigen 1 with adjuvant AS01B administered alone or concurrently with the RTS, S/AS01B vaccine in rhesus primates. Infect Immun 76(1):229-238.
20. Kester KE, et al.; RTS, S Vaccine Evaluation Group (2009) Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS, S/AS01B and RTS, S/AS02A in malarianaive adults: Safety, efficacy, and immunologic associates of protection. J Infect Dis 200(3):337-346.
21. Ndungu FM, et al. (2012) A statistical interaction between circumsporozoite proteinspecific T cell and antibody responses and risk of clinical malaria episodes following vaccination with RTS, S/AS01E. PLoS ONE 7(12):e52870.
22. Kumar KA, et al. (2006) The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites. Nature 444(7121):937-940.
23. Grüner AC, et al. (2007) Sterile protection against malaria is independent of immune responses to the circumsporozoite protein. PLoS ONE 2(12):e1371.
24. Mauduit M, et al. (2010) Minimal role for the circumsporozoite protein in the induction of sterile immunity by vaccination with live rodent malaria sporozoites. Infect Immun 78(5):2182-2188.
25. Mauduit M, et al. (2009) A role for immune responses against non-CS components in the cross-species protection induced by immunization with irradiated malaria sporozoites. PLoS ONE 4(11):e7717.
26. Belnoue E, et al. (2004) Protective T cell immunity against malaria liver stage after vaccination with live sporozoites under chloroquine treatment. J Immunol 172(4):2487-2495.
27. Butler NS, et al. (2011) Superior antimalarial immunity after vaccination with late liver stage-arresting genetically attenuated parasites. Cell Host Microbe 9(6):451-462.
28. Mishra S, et al. (2011) Identification of non-CSP antigens bearing CD8 epitopes in mice immunized with irradiated sporozoites. Vaccine 29(43):7335-7342.
29. Reyes-Sandoval A, Pearson FE, Todryk S, Ewer K (2009) Potency assays for novel T-cellinducing vaccines against malaria. Curr Opin Mol Ther 11(1):72-80.
30. Doolan DL, et al. (2003) Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data. Proc Natl Acad Sci USA 100(17):9952-9957.
31. Wang R, et al. (2005) Immune responses to Plasmodium vivax pre-erythrocytic stage antigens in naturally exposed Duffy-negative humans: A potential model for identification of liver-stage antigens. Eur J Immunol 35(6):1859-1868.
32. Hondowicz BD, et al. (2012) Discovery of T cell antigens by high-throughput screening of synthetic minigene libraries. PLoS ONE 7(1):e29949.
33. Sacci JB, Jr., Aguiar JC, Lau AO, Hoffman SL (2002) Laser capture microdissection and molecular analysis of Plasmodium yoelii liver-stage parasites. Mol Biochem Parasitol 119(2):285-289.
34. Artavanis-Tsakonas K, Riley EM (2002) Innate immune response to malaria: Rapid induction of IFN-gamma from human NK cells by live Plasmodium falciparum-infected erythrocytes. J Immunol 169(6):2956-2963.
35. Schwartz JJ, Lee C, Shendure J (2012) Accurate gene synthesis with tag-directed retrieval of sequence-verified DNA molecules. Nat Methods 9(9):913-915.
36. Ma S, Saaem I, Tian J (2012) Error correction in gene synthesis technology. Trends Biotechnol 30(3):147-154.
37. Schmidt NW, Butler NS, Badovinac VP, Harty JT (2010) Extreme CD8 T cell requirements for anti-malarial liver-stage immunity following immunization with radiation attenuated sporozoites. PLoS Pathog 6(7):e1000998.
38. Hafalla JC, et al. (2006) Priming of CD8+ T cell responses following immunization with heat-killed Plasmodium sporozoites. Eur J Immunol 36(5):1179-1186.
39. Zhou Y, et al. (2008) Evidence-based annotation of the malaria parasite' s genome using comparative expression profiling. PLoS One 3(2):e1570.
40. Tarun AS, et al. (2008) A combined transcriptome and proteome survey of malaria parasite liver stages. Proc Natl Acad Sci USA 105(1):305-310.
41. Le Roch KG, et al. (2003) Discovery of gene function by expression profiling of the malaria parasite life cycle. Science 301(5639):1503-1508.
42. Florens L, et al. (2002) A proteomic view of the Plasmodium falciparum life cycle. Nature 419(6906):520-526.
43. Le Roch KG, et al. (2004) Global analysis of transcript and protein levels across the Plasmodium falciparum life cycle. Genome Res 14(11):2308-2318.
44. Hall N, et al. (2005) A comprehensive survey of the Plasmodium life cycle by genomic, transcriptomic, and proteomic analyses. Science 307(5706):82-86.
45. Lau LS, et al. (2011) Blood-stage Plasmodium berghei infection generates a potent, specific CD8+ T-cell response despite residence largely in cells lacking MHC I processing machinery. J Infect Dis 204(12):1989-1996.
46. Butler NS, Vaughan AM, Harty JT, Kappe SH (2012) Whole parasite vaccination approaches for prevention of malaria infection. Trends Immunol 33(5):247-254.
47. Hafalla JC, et al. (2003) Early self-regulatory mechanisms control the magnitude of CD8+ T cell responses against liver stages of murine malaria. J Immunol 171(2):964-970.
48. Cockburn IA, Chakravarty S, Overstreet MG, García-Sastre A, Zavala F (2008) Memory CD8+ T cell responses expand when antigen presentation overcomes T cell self-regulation. J Immunol 180(1):64-71.
49. Porter DW, et al. (2011) A human Phase I/IIa malaria challenge trial of a polyprotein malaria vaccine. Vaccine 29(43):7514-7522.
50. Müllbacher A, Lobigs M, Kos FJ, Langman R (1999) Alloreactive cytotoxic T-cell function, peptide nonspecific. Scand J Immunol 49(6):563-569.
51. Moon JJ, et al. (2009) Tracking epitope-specific T cells. Nat Protoc 4(4):565-581.
52. Sano G, et al. (2001) Swift development of protective effector functions in naive CD8(+) T cells against malaria liver stages. J Exp Med 194 (2):173-180.
53. Zehn D, Lee SY, Bevan MJ (2009) Complete but curtailed T-cell response to very lowaffinity antigen. Nature 458(7235):211-214.